Member of Lyonbiopole
Development of innovative therapies for the treatment of resistant cancers by targeting Aldehyde Dehydrogenases.
Strategic application domain: Human Medicine
Application market: Oncology
Type of activity: CRO - Tools - R&D platform, Diagnostics, Therapeutics, Pharma or Biotech
Technologies: Molecular Biology & Nucleic acid, Small Molecules
Created on aug. 2nd, 2010 - 25 employees
Address
Parc Technologique de Lyon - 655, Allée des Parcs - Bâtiment D - 69800 Saint Priest - France 69800 St Priest
You must be logged in and a member of Lyonbiopôle to see the contacts.
